logo for Eli Lilly Italia SpA

Eli Lilly Italia SpA

Manufacturing · Italy · 1K - 5K Employees

View Company Info for Free

Overview

Headquarters

Via Gramsci 731-733, Sesto Fiorentino, T...

Phone Number

+39 5542571

Revenue

$369.6 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1

About Eli Lilly Italia SpA

Eli Lilly Italia SpA, established in Italy over 60 years ago with headquarters in Sesto Fiorentino, is a pharmaceutical company specializing in biotechnology drugs. The company operates one of Italy's most innovative production facilities, focusing on manufacturing recombinant DNA insulin for European and global markets. As part of the global Eli Lilly organization founded in 1876, the Italian subsidiary serves both business and consumer markets in the pharmaceutical and healthcare sectors. The company maintains extensive operations including research and development, manufacturing, and distribution facilities to support its mission of providing advanced medical solutions.Explore more
Eli Lilly Italia SpA's Social MediaPopular SearchesEli Lilly Italia SpaELI Lilly ItaliaEli Lilly Italia - SpaEli LillyEli Lilly ItalySIC Code 28,283NAICS Code 32,325Show more

Is Eli Lilly Italia SpA your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Eli Lilly Italia SpA

Compare insights from companies similar to Eli Lilly Italia SpA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Eli Lilly Italia SpA

$369.6M
1K - 5K
Private
-
1876
N/A
$65.8B
10K+
Public
$20.9B
1891
AM
Allyson MunsellChief of Staff To the Senior Vice President, Global Communications
$63.3B
10K+
Public
$1.3B
1849
SK
Suraj KhandekarHealthcare Executive
$56.7B
10K+
Public
-
1996
DC
Daniela CastanedaImmunology Director, Commercial Operations & Chief of Staff
$48.5B
10K+
Public
$4B
1887
IC
Imara CharlesVice President, Chief of Staff, Global Product Development & Supply
$42.1B
10K+
Public
-
1923
Vincent Lamanna, President & General Manager, Novo Nordisk (Canada) at Novo Nordisk
Vincent LamannaPresident & General Manager, Novo Nordisk (Canada)
$12.8B
10K+
Public
-
2005
Hiroyuki Okuzawa, Chief Financial Officer at Daiichi Sankyo
Hiroyuki OkuzawaChief Financial Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Eli Lilly Italia SpA is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Eli Lilly Italia SpA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eli Lilly Italia SpA.

Top Manufacturing Companies

Frequently Asked Questions Regarding Eli Lilly Italia SpA

What is Eli Lilly Italia SpA's Revenue?
Eli Lilly Italia SpA's revenue is $369.6 Million
What is Eli Lilly Italia SpA's SIC code?
Eli Lilly Italia SpA's SIC: 28,283
What is Eli Lilly Italia SpA's NAICS code?
Eli Lilly Italia SpA's NAICS: 32,325
How many employees does Eli Lilly Italia SpA have?
Eli Lilly Italia SpA has 1K - 5K employees
What industry does Eli Lilly Italia SpA belong to?
Eli Lilly Italia SpA is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Eli Lilly Italia SpA competition?
Eli Lilly Italia SpA top competitors include: Pfizer, Novo Nordisk, Merck, Novartis
What companies has Eli Lilly Italia SpA acquired?
Eli Lilly Italia SpA has acquired the companies: SGX Pharmaceuticals, CrossBridge Bio, Vaccine Company, CoLucid Pharmaceuticals
What does Eli Lilly Italia SpA do?

Eli Lilly Italia SpA, established in Italy over 60 years ago with headquarters in Sesto Fiorentino, is a pharmaceutical company specializing in biotechnology drugs. The company operates one of Italy's most innovative production facilities, focusing on manufacturing recombinant DNA insulin for European and global markets. As part of the global Eli L... illy organization founded in 1876, the Italian subsidiary serves both business and consumer markets in the pharmaceutical and healthcare sectors. The company maintains extensive operations including research and development, manufacturing, and distribution facilities to support its mission of providing advanced medical solutions.Read More

What are Eli Lilly Italia SpA social media links?
Eli Lilly Italia SpA Linkedin page Eli Lilly Italia SpA Twitter page Eli Lilly Italia SpA Facebook page
Is Eli Lilly Italia SpA a public company?
Eli Lilly Italia SpA is private company therefore does not currently have an official ticker symbol
See more information about Eli Lilly Italia SpA

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.